Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Sponsor content
359 result(s) found, displaying 201 to 210
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Designation or determinationProvisional approval
-
Designation or determinationProvisional approval
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ISENTRESS HD raltegravir 600 mg tablet bottle.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Prescription medicine registrationActive ingredients: ceftolozane sulfate; tazobactam sodium.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate